Compound for treating vascular malformation
A vascular and malformation technology, applied in the field of compounds for the treatment of vascular malformations, can solve problems such as ineffective treatment of vascular malformations
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030] Application of CysLTR1 antagonist in preparation of medicine for treating vascular malformation.
[0031] In some instances, the vascular malformation is a vascular malformation caused by abnormal expression of DDX24.
[0032] In some examples, the vascular malformation includes portal vein stenosis, hepatic vein stenosis, pulmonary valve stenosis, chylothorax, portal hypertension, MOVLD syndrome, idiopathic noncirrhotic portal hypertension.
[0033] In some examples, the CysLTRl antagonist is selected from montelukast sodium, Zafirlukast, Cinalukast, Nedocromil, Pranlukast, and pharmaceutically acceptable derivatives thereof.
[0034] A method of treating vascular malformations comprising administering to a patient a therapeutically effective amount of a CysLTRl antagonist.
[0035] In some instances, the vascular malformation is a vascular malformation caused by abnormal expression of DDX24.
[0036] In some examples, the vascular malformation includes portal vein s...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


